Anne Beal, MD, MPH Joins Omada Health Board of Directors
New AI-agent, OmadaSpark, works alongside care teams to provide real-time educational support for nutrition questions, motivational challenges, and building healthy habits
SAN FRANCISCO, CA, October 9, 2024 – Omada Health, the virtual between-visit healthcare provider, is proud to announce the addition of Anne Beal, MD, MPH, to Omada’s Board of Directors.
“Dr. Beal has been a champion for integrating patient voices into research and advancing innovation centered on patient experience and clinical outcomes, which are key factors for sustainable market growth,” said Sean Duffy, CEO and Co-Founder of Omada Health. “We believe that her track record on the boards of both public and private companies, combined with her leadership roles at respected life sciences and non-profit organizations, will be a valuable addition to Omada as we scale our programs to serve diverse patient populations and address their evolving care needs.”
Dr. Beal is a recognized leader in healthcare with a distinguished career in clinical practice, research, and healthcare organizations. She currently serves on the boards of GSK plc and Prolacta Bioscience and has held key leadership positions as Chief Patient Officer at Sanofi, Deputy Executive Director and Chief Engagement Officer at the Patient-Centered Outcomes Research Institute (PCORI), and senior roles at the Aetna Foundation and the Commonwealth Fund.
Prior to her corporate leadership roles, she was a member of the pediatrics faculty at Harvard Medical School and Massachusetts General Hospital. Dr. Beal earned her medical degree from Cornell University Medical College and completed her residency in pediatrics at Albert Einstein College of Medicine/Montefiore Medical Center. She holds a Master’s in Public Health from Columbia University.
“I am excited to join Omada’s Board of Directors and contribute to a company that places clinical evidence at the forefront of healthcare innovation,” said Dr. Beal. “There is a growing need for patient-centered solutions that extend care beyond traditional doctor’s visits, to meet patients where they are. I look forward to collaborating with the Board and the Omada leadership team to help expand virtual care access for individuals living with chronic conditions.”
